Certara Logo White Background.png
Certara Reports Third Quarter 2022 Financial Results
November 07, 2022 16:15 ET | Certara
PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the third quarter of fiscal year 2022 and...
Certara Logo White Background.png
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
November 07, 2022 08:00 ET | Certara
PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and...
Certara Logo White Background.png
Certara to Participate in Upcoming Investor Conferences
November 02, 2022 17:00 ET | Certara
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Certara Logo White Background.png
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
October 19, 2022 08:00 ET | Certara
PRINCETON, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Certara, Inc., (Nasdaq: CERT) a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)...
Certara Logo White Background.png
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
October 13, 2022 07:45 ET | Certara
PRINCETON, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Global Biosimulation Market
Global Biosimulation Market Report 2022: Growing Number of Relapse Cases Due to Increasing Drug Resistance Bolsters Sector
September 27, 2022 05:08 ET | Research and Markets
Dublin, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market Size, Share & Trends Analysis Report by Product (Software, Services), by Application (Drug Development, Drug...
Certara Logo White Background.png
Certara to Participate in Upcoming Investor Conferences
August 31, 2022 08:00 ET | Certara
PRINCETON, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Global Biosimulation Market
Biosimulation Global Market Report 2022-2026: Key Players Certara, Dassault, Schrodinger & Others Driving 13.9% Growth
August 25, 2022 05:33 ET | Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Biosimulation Global Market Report 2022, By Product, Application, End User" report has been added to ResearchAndMarkets.com's offering. The global...
Certara Logo White Background.png
Certara Reports Second Quarter 2022 Financial Results
August 09, 2022 16:15 ET | Certara
PRINCETON, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the second quarter of fiscal year 2022 and...
Certara Logo White Background.png
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
July 28, 2022 08:00 ET | Certara
PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a 2-year collaboration with Memorial Sloan Kettering Cancer Center...